Eukles Asset Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.41M | Sell |
9,471
-281
| -3% | -$65.5K | 0.99% | 35 |
|
|
2026
Q1 | $2.38M | Sell |
9,752
-954
| -9% | -$222K | 1.06% | 34 |
|
|
2025
Q4 | $2.22M | Sell |
10,706
-205
| -2% | -$40.5K | 0.86% | 41 |
|
|
2025
Q3 | $2.02M | Sell |
10,911
-115
| -1% | -$19.7K | 0.79% | 42 |
|
|
2025
Q2 | $1.68M | Sell |
11,026
-129
| -1% | -$19.8K | 0.69% | 47 |
|
|
2025
Q1 | $1.85M | Buy |
11,155
+89
| +0.8% | +$13.9K | 0.81% | 44 |
|
|
2024
Q4 | $1.6M | Sell |
11,066
-294
| -3% | -$45.6K | 0.68% | 50 |
|
|
2024
Q3 | $1.84M | Sell |
11,360
-584
| -5% | -$93K | 0.74% | 47 |
|
|
2024
Q2 | $1.75M | Buy |
11,944
+92
| +0.8% | +$13.7K | 0.76% | 45 |
|
|
2024
Q1 | $1.87M | Buy |
11,852
+559
| +5% | +$89K | 0.82% | 42 |
|
|
2023
Q4 | $1.77M | Buy |
11,293
+29
| +0.3% | +$4.45K | 0.84% | 42 |
|
|
2023
Q3 | $1.75M | Buy |
11,264
+118
| +1% | +$19.5K | 0.93% | 38 |
|
|
2023
Q2 | $1.84M | Buy |
11,146
+133
| +1% | +$21.5K | 0.94% | 38 |
|
|
2023
Q1 | $1.71M | Buy |
11,013
+35
| +0.3% | +$5.65K | 0.93% | 42 |
|
|
2022
Q4 | $1.94M | Buy |
10,978
+372
| +4% | +$64.2K | 1.13% | 34 |
|
|
2022
Q3 | $1.73M | Buy |
10,606
+744
| +8% | +$126K | 1.14% | 35 |
|
|
2022
Q2 | $1.75M | Buy |
9,862
+53
| +0.5% | +$9.44K | 1.11% | 34 |
|
|
2022
Q1 | $1.74M | Sell |
9,809
-771
| -7% | -$131K | 0.94% | 39 |
|
|
2021
Q4 | $1.81M | Buy |
10,580
+304
| +3% | +$49.8K | 0.88% | 45 |
|
|
2021
Q3 | $1.66M | Sell |
10,276
-325
| -3% | -$55.4K | 0.91% | 42 |
|
|
2021
Q2 | $1.75M | Buy |
10,601
+1,587
| +18% | +$263K | 0.97% | 40 |
|
|
2021
Q1 | $1.48M | Buy |
9,014
+170
| +2% | +$27.5K | 0.96% | 41 |
|
|
2020
Q4 | $1.39M | Buy |
8,844
+190
| +2% | +$28K | 0.96% | 42 |
|
|
2020
Q3 | $1.29M | Buy |
8,654
+112
| +1% | +$16.6K | 1% | 39 |
|
|
2020
Q2 | $1.2M | Buy |
8,542
+1,112
| +15% | +$162K | 1.02% | 42 |
|
|
2020
Q1 | $974K | Sell |
7,430
-1,275
| -15% | -$181K | 1.01% | 42 |
|
|
2019
Q4 | $1.27M | Sell |
8,705
-112
| -1% | -$15.2K | 1.03% | 41 |
|
|
2019
Q3 | $1.14M | Sell |
8,817
-24
| -0.3% | -$3.16K | 0.99% | 45 |
|
|
2019
Q2 | $1.23M | Sell |
8,841
-61
| -0.7% | -$8.44K | 1.07% | 42 |
|
|
2019
Q1 | $1.24M | Buy |
8,902
+27
| +0.3% | +$3.62K | 1.13% | 41 |
|
|
2018
Q4 | $1.15M | Buy |
+8,875
| New | +$1.24M | 1.19% | 38 |
|
Other funds holding JNJ
Eukles Asset Management's JNJ Position: Q2 2026 in Review
Eukles Asset Management reduced its Johnson & Johnson (JNJ) stake by 2.9% in Q2 2026, selling an estimated $65.5K and leaving 9,471 shares worth $2.41M. The position accounts for 0.99% of the portfolio, ranked #35.
Eukles Asset Management first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Eukles Asset Management held 9,471 shares of Johnson & Johnson worth $2.41M as of Q2 2026.
- Eukles Asset Management sold 281 Johnson & Johnson shares in Q2 2026, an estimated $65.5K.
- Johnson & Johnson made up 0.99% of Eukles Asset Management's portfolio in Q2 2026, its #35 holding.
- Eukles Asset Management first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Eukles Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.